FDA head urges probe of agency’s dealings with maker of controversial Alzheimer’s drug

FDA Narrows Guidance On New Alzheimer's Drug Amid Criticism

Watch VideoThe acting head of the Food and Drug Administration on Friday called for a government investigation into highly unusual..